1. Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines
   Elisabeth Enzenhofer et al, 2017, Head & Neck CrossRef
2. Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma
   Bih-Rong Wei et al, 2020, Molecular Cancer Therapeutics CrossRef
3. Genus Knema: An Extensive Review on Traditional Uses, Phytochemistry, and Pharmacology
   Nguyen Quang Hop et al, 2023, Current Pharmaceutical Biotechnology CrossRef
4. miR-153 regulates apoptosis and autophagy of cardiomyocytes by targeting Mcl-1
   YUHAI ZOU et al, 2016, Molecular Medicine Reports CrossRef
5. CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer
   Lyla J. Stanland et al, 2023, Molecular Cancer Research CrossRef
6. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
   Julian C. Bahr et al, 2016, Oncotarget CrossRef
7. Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
   Geoffrey I. Shapiro et al, 2020, Investigational New Drugs CrossRef
8. Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma
   Ruchi P. Patel et al, 2021, Investigative Opthalmology & Visual Science CrossRef
9. CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
   Cheng Hu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
10. Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway
    Anjali Lathwal et al, 2019, PLOS ONE CrossRef
11. Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells
    Zahra Fakhroueian et al, 2022, Anti-Cancer Drugs CrossRef
12. T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer
    Satomi Watanabe et al, 2017, Molecular Cancer Therapeutics CrossRef
13. Maleimide-Functionalized PEI600 Grafted Polyurethane: Synthesis, Nano-Complex Formation with DNA and Thiol-Conjugation of the Complexes for Dual DNA Transfection
    Wei-Chih Hung et al, 2015, Polymers CrossRef